N-cadherin expression is a potential survival mechanism of gefitinib-resistant lung cancer cells

Non-small cell lung cancer (NSCLC) is a major subtype of lung cancer and is the most common and fatal cancer worldwide. Specific tyrosine kinase inhibitors for epidermal growth factor receptor (EGFR), such as gefitinib, have been effective in some NSCLC patients and are being used in the clinical se...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yamauchi, Mai, Yoshino, Ikuyo, Yamaguchi, Rui, Shimamura, Teppei, Nagasaki, Masao, Imoto, Seiya, Niida, Atsushi, Koizumi, Fumiaki, Kohno, Takashi, Yokota, Jun, Miyano, Satoru, Gotoh, Noriko
Formato: Artigo
Lenguaje:Inglês
Publicado: e-Century Publishing Corporation 2011
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3196281/
https://ncbi.nlm.nih.gov/pubmed/22016830
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares